微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 45.35% | 16.72% | 1.76% | 27/140 | 55.6% | 九强生物 | 80.86% | 行业排名> |
| 2026-03-31 | 44.56% | 4.18% | 9.84% | 85/140 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 40.57% | -21.47% | 21.45% | 90/140 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 33.41% | -23.04% | -14.01% | 103/140 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 38.85% | -9.85% | -9.17% | 94/140 | 52.44% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 42.78% | 17.52% | -17.2% | 84/140 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 51.66% | 2.24% | 19.02% | 75/140 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 43.41% | -12.92% | 0.73% | 86/140 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 43.1% | -13% | 18.4% | 89/140 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 36.4% | -29.19% | -27.97% | 98/140 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 50.53% | -2.8% | 1.37% | 75/140 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 49.85% | -5.72% | 0.63% | 75/140 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 49.54% | -4.56% | -3.63% | 75/140 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 51.4% | -3.4% | -1.13% | 74/140 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 51.99% | -0.65% | -1.68% | 76/140 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 52.88% | 0.37% | 1.87% | 74/140 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 51.91% | -1.4% | -2.45% | 76/140 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 53.21% | -4.29% | 1.69% | 70/140 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 52.33% | -6.07% | -0.66% | 83/140 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 52.68% | -8.9% | 0.07% | 72/140 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 52.64% | -9.55% | -5.32% | 77/140 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 55.6% | -11.54% | -0.2% | 65/140 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 55.71% | -13.54% | -3.66% | 80/140 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 57.83% | -11.36% | -0.63% | 56/140 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 58.19% | -9.87% | -7.41% | 65/140 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 62.85% | -2.72% | -2.46% | 36/140 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 64.44% | -1.03% | -1.23% | 55/140 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 65.24% | -0.09% | 1.04% | 26/140 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 64.57% | -0.68% | -0.07% | 35/140 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 64.61% | -3.15% | -0.77% | 22/140 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 65.11% | 1.28% | -0.29% | 44/140 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 65.3% | 1.07% | 0.45% | 19/140 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 65.01% | 2.21% | -2.55% | 24/140 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 66.71% | 0.44% | 3.77% | 17/140 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 64.28% | 2.68% | -0.5% | 42/140 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 64.61% | 2.33% | 1.58% | 19/140 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 63.6% | 2.44% | -4.24% | 24/140 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 66.42% | 9.53% | 6.09% | 14/140 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 62.61% | 6.47% | -0.84% | 36/140 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 63.13% | 11.93% | 1.69% | 13/140 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 62.08% | 12.72% | 2.39% | 18/140 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 60.64% | 6.18% | 3.12% | 10/140 | 50.24% | 健帆生物 | 83.86% | 行业排名> |